BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Saba Capital Management, L.P. Purchases 8,012 Shares

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. acquired 8,012 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The stock was acquired at an average price of 15.84 per share, with a total value of 126,910.08. Following the acquisition, the insider now owns 20,661,390 shares in the company, valued at 327,276,417.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Friday, September 27th, Saba Capital Management, L.P. purchased 1,633 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.89 per share, with a total value of 25,948.37.
• On Wednesday, September 25th, Saba Capital Management, L.P. acquired 300 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.73 per share, for a total transaction of 4,719.00.
• On Monday, September 23rd, Saba Capital Management, L.P. bought 2,006 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.98 per share, with a total value of 32,055.88.
• On Thursday, September 19th, Saba Capital Management, L.P. purchased 15,455 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 16.14 per share, for a total transaction of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. acquired 27,148 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average cost of 15.93 per share, for a total transaction of 432,467.64.

BlackRock Health Sciences Term Trust Price Performance

NYSE:BMEZ opened at 15.76 on Friday. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59. The company has a 50 day simple moving average of 15.85 and a two-hundred day simple moving average of 15.53.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be given a dividend of $0.176 per share. This represents a $2.11 annualized dividend and a dividend yield of 13.40%. The ex-dividend date of this dividend is Tuesday, October 15th.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Benjamin F. Edwards & Company Inc. grew its holdings in BlackRock Health Sciences Term Trust by 21.7% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock worth $96,000 after acquiring an additional 1,038 shares during the period. Register Financial Advisors LLC boosted its position in shares of BlackRock Health Sciences Term Trust by 5,365.6% during the 2nd quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock valued at $105,000 after purchasing an additional 6,707 shares in the last quarter. Shaker Financial Services LLC acquired a new stake in BlackRock Health Sciences Term Trust during the second quarter worth approximately $184,000. Comerica Bank grew its stake in BlackRock Health Sciences Term Trust by 31.1% during the first quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after purchasing an additional 3,671 shares during the period. Finally, B. Riley Wealth Advisors Inc. bought a new stake in BlackRock Health Sciences Term Trust in the first quarter worth approximately $285,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.